Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1988 Dec 24;297(6664):1629–1631. doi: 10.1136/bmj.297.6664.1629

Vindaloo and you.

I Bjarnason 1, S Levi 1, P Smethurst 1, I S Menzies 1, A J Levi 1
PMCID: PMC1838850  PMID: 3147764

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Auer I. O., Habscheid W., Hiller S., Gerhards W., Eilles C. Nicht-steroidale Antiphlogistika erhöhen die Darmpermeabilität. Dtsch Med Wochenschr. 1987 Jun 26;112(26):1032–1037. doi: 10.1055/s-2008-1068189. [DOI] [PubMed] [Google Scholar]
  2. Baker S. J. Geographical variations in the morphology of the small intestinal mucosa in apparently healthy individuals. Pathol Microbiol (Basel) 1973;39(3):222–237. doi: 10.1159/000162651. [DOI] [PubMed] [Google Scholar]
  3. Baker S. J., Mathan V. I. Syndrome of tropical sprue in South India. Am J Clin Nutr. 1968 Sep;21(9):984–993. doi: 10.1093/ajcn/21.9.984. [DOI] [PubMed] [Google Scholar]
  4. Bjarnason I., Peters J. Helping the mucosa make sense of macromolecules. Gut. 1987 Sep;28(9):1057–1061. doi: 10.1136/gut.28.9.1057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bjarnason I., Peters T. J., Levi A. J. Intestinal permeability: clinical correlates. Dig Dis. 1986;4(2):83–92. doi: 10.1159/000171140. [DOI] [PubMed] [Google Scholar]
  6. Bjarnason I., Peters T. J., Veall N. 51Cr-EDTA test for intestinal permeability. Lancet. 1984 Sep 1;2(8401):523–523. doi: 10.1016/s0140-6736(84)92601-1. [DOI] [PubMed] [Google Scholar]
  7. Bjarnason I., Peters T. J., Wise R. J. The leaky gut of alcoholism: possible route of entry for toxic compounds. Lancet. 1984 Jan 28;1(8370):179–182. doi: 10.1016/s0140-6736(84)92109-3. [DOI] [PubMed] [Google Scholar]
  8. Bjarnason I., Price A. B., Zanelli G., Smethurst P., Burke M., Gumpel J. M., Levi A. J. Clinicopathological features of nonsteroidal antiinflammatory drug-induced small intestinal strictures. Gastroenterology. 1988 Apr;94(4):1070–1074. doi: 10.1016/0016-5085(88)90568-9. [DOI] [PubMed] [Google Scholar]
  9. Bjarnason I., Williams P., Smethurst P., Peters T. J., Levi A. J. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine. Gut. 1986 Nov;27(11):1292–1297. doi: 10.1136/gut.27.11.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Bjarnason I., Williams P., So A., Zanelli G. D., Levi A. J., Gumpel J. M., Peters T. J., Ansell B. Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs. Lancet. 1984 Nov 24;2(8413):1171–1174. doi: 10.1016/s0140-6736(84)92739-9. [DOI] [PubMed] [Google Scholar]
  11. Bjarnason I., Zanelli G., Prouse P., Smethurst P., Smith T., Levi S., Gumpel M. J., Levi A. J. Blood and protein loss via small-intestinal inflammation induced by non-steroidal anti-inflammatory drugs. Lancet. 1987 Sep 26;2(8561):711–714. doi: 10.1016/s0140-6736(87)91075-0. [DOI] [PubMed] [Google Scholar]
  12. Brunser O., Eidelman S., Klipstein F. A. Intestinal morphology of rural Haitians. A comparison between overt tropical sprue and asymptomatic subjects. Gastroenterology. 1970 May;58(5):655–668. [PubMed] [Google Scholar]
  13. Casellas F., Aguadé S., Soriano B., Accarino A., Molero J., Guarner L. Intestinal permeability to 99mTc-diethylenetriaminopentaacetic acid in inflammatory bowel disease. Am J Gastroenterol. 1986 Sep;81(9):767–770. [PubMed] [Google Scholar]
  14. Chadwick V. S., Phillips S. F., Hofmann A. F. Measurements of intestinal permeability using low molecular weight polyethylene glycols (PEG 400). II. Application to normal and abnormal permeability states in man and animals. Gastroenterology. 1977 Aug;73(2):247–251. [PubMed] [Google Scholar]
  15. Jenkins R. T., Jones D. B., Goodacre R. L., Collins S. M., Coates G., Hunt R. H., Bienenstock J. Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases. Am J Gastroenterol. 1987 Nov;82(11):1159–1164. [PubMed] [Google Scholar]
  16. Jenkins R. T., Rooney P. J., Jones D. B., Bienenstock J., Goodacre R. L. Increased intestinal permeability in patients with rheumatoid arthritis: a side-effect of oral nonsteroidal anti-inflammatory drug therapy? Br J Rheumatol. 1987 Apr;26(2):103–107. doi: 10.1093/rheumatology/26.2.103. [DOI] [PubMed] [Google Scholar]
  17. Kumar D., Wingate D. L. The irritable bowel syndrome: a paroxysmal motor disorder. Lancet. 1985 Nov 2;2(8462):973–977. doi: 10.1016/s0140-6736(85)90525-2. [DOI] [PubMed] [Google Scholar]
  18. Leclercq-Foucart J., Forget P. P., Van Cutsem J. L. Lactulose-rhamnose intestinal permeability in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1987 Jan-Feb;6(1):66–70. doi: 10.1097/00005176-198701000-00012. [DOI] [PubMed] [Google Scholar]
  19. Leclercq-Foucart J., Forget P., Sodoyez-Goffaux F., Zappitelli A. Intestinal permeability to [51Cr]EDTA in children with cystic fibrosis. J Pediatr Gastroenterol Nutr. 1986 May-Jun;5(3):384–387. doi: 10.1097/00005176-198605000-00008. [DOI] [PubMed] [Google Scholar]
  20. Lindenbaum J., Harmon J. W., Gerson C. D. Subclinical malabsorption in developing countries. Am J Clin Nutr. 1972 Oct;25(10):1056–1061. doi: 10.1093/ajcn/25.10.1056. [DOI] [PubMed] [Google Scholar]
  21. Menzies I. S., Mount J. N., Wheeler M. J. Quantitative estimation of clinically important monosaccharides in plasma by rapid thin layer chromatography. Ann Clin Biochem. 1978 Mar;15(2):65–76. doi: 10.1177/000456327801500116. [DOI] [PubMed] [Google Scholar]
  22. Mylotte M., Egan-Mitchell B., McCarthy C. F., McNicholl B. Incidence of coeliac disease in the West of Ireland. Br Med J. 1973 Mar 24;1(5855):703–705. doi: 10.1136/bmj.1.5855.703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. O'Mahony C. P., Stevens F. M., Bourke M., McCarthy C. F., Weir D. G., Feighery C. F. 51Cr-EDTA test for coeliac disease. Lancet. 1984 Jun 16;1(8390):1354–1355. doi: 10.1016/s0140-6736(84)91850-6. [DOI] [PubMed] [Google Scholar]
  24. O'Morain C. A., Abelow A. C., Chervu L. R., Fleischner G. M., Das K. M. Chromium 51-ethylenediaminetetraacetate test: a useful test in the assessment of inflammatory bowel disease. J Lab Clin Med. 1986 Nov;108(5):430–435. [PubMed] [Google Scholar]
  25. Peled Y., Watz C., Gilat T. Measurement of intestinal permeability using 51Cr-EDTA. Am J Gastroenterol. 1985 Oct;80(10):770–773. [PubMed] [Google Scholar]
  26. Peters T. J., Bjarnason I. Coeliac syndrome: biochemical mechanisms and the missing peptidase hypothesis revisted. Gut. 1984 Sep;25(9):913–918. doi: 10.1136/gut.25.9.913. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Ruppin H., Hotze A., Düring A., Reichert M., Bauer J., Stoll R., Herbst M., Mahlstedt J. Reversible Funktionsstörungen des Intestinaltraktes durch abdominelle Strahlentherapie. Z Gastroenterol. 1987 May;25(5):261–269. [PubMed] [Google Scholar]
  28. Schenk E. A., Klipstein F. A., Tomasini J. T. Morphologic characteristics of jejunal biopsies from asymptomatic Haitians and Puerto Ricans. Am J Clin Nutr. 1972 Oct;25(10):1080–1083. doi: 10.1093/ajcn/25.10.1080. [DOI] [PubMed] [Google Scholar]
  29. Turck D., Ythier H., Maquet E., Deveaux M., Marchandise X., Farriaux J. P., Fontaine G. Intestinal permeability to [51Cr]EDTA in children with Crohn's disease and celiac disease. J Pediatr Gastroenterol Nutr. 1987 Jul-Aug;6(4):535–537. doi: 10.1097/00005176-198707000-00007. [DOI] [PubMed] [Google Scholar]
  30. Ukabam S. O., Homeida M. M., Cooper B. T. Small intestinal permeability in normal Sudanese subjects: evidence of tropical enteropathy. Trans R Soc Trop Med Hyg. 1986;80(2):204–207. doi: 10.1016/0035-9203(86)90010-6. [DOI] [PubMed] [Google Scholar]
  31. Walker W. A., Isselbacher K. J. Uptake and transport of macromolecules by the intestine. Possible role in clinical disorders. Gastroenterology. 1974 Sep;67(3):531–550. [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES